In recent years, the clinical efficacy of traditional Chinese medicine (TCM) in treating malignant tumor has attracted more and more attention of oncologic societies at home and abroad. What is the superiority of TCM in treating malignant tumor? And what is the bottleneck of clinical trial of TCM? These are the major research topic to be recognized by TCM society since many years ago.
展开▼
机译:Yang Nianqun, Zaizao Bingren: Zhong Xi Yi Chongtu Xia De Kongjian Zhengzhi, 1832-1985 [Remaking "Patients": Politics of Space in the Conflicts between Traditional Chinese Medicine and Western Medicine, 1832-1985]
机译:Angela Ki-che Leung, Miandui jibing: Chuantong zhongguo shehui de yiliao guannian yu zuzhi 面对疾病:传统中国社会 的医疗观念与组织[In the Face of Disease: Concepts and Institutions of Medicine in Traditional Chinese Society]
机译:信息不对称下,“中药材全产业链服务商”模式对中药材价格的影响研究 =Pricing and Information Asymmetry in the Chinese Herbal Medicine Markets - A Study of the Mode of "Chinese Herbal Medicine Industry Chain Service Provider"
机译:Retraction statement: ‘Formin‐like2 regulates Rho/ROCK pathway to promote actin assembly and cell invasion of colorectal cancer’ by Yuanfeng Zeng Huijun Xie Yudan Qiao Jianmei Wang Xiling Zhu Guoyang He Yuling Li Xiaoli Ren Feifei Wang Li Liang and Yanqing Ding